21-34370795-C-T
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_172201.2(KCNE2):c.317C>T(p.Ser106Leu) variant causes a missense change. The variant allele was found at a frequency of 0.000107 in 1,614,146 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_172201.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KCNE2 | NM_172201.2 | c.317C>T | p.Ser106Leu | missense_variant | Exon 2 of 2 | ENST00000290310.4 | NP_751951.1 | |
LOC105372791 | NR_188571.1 | n.492G>A | non_coding_transcript_exon_variant | Exon 2 of 3 | ||||
LOC105372791 | NR_188572.1 | n.492G>A | non_coding_transcript_exon_variant | Exon 2 of 2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000598 AC: 91AN: 152150Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000211 AC: 53AN: 251396Hom.: 0 AF XY: 0.000191 AC XY: 26AN XY: 135882
GnomAD4 exome AF: 0.0000561 AC: 82AN: 1461878Hom.: 0 Cov.: 31 AF XY: 0.0000523 AC XY: 38AN XY: 727238
GnomAD4 genome AF: 0.000598 AC: 91AN: 152268Hom.: 0 Cov.: 32 AF XY: 0.000792 AC XY: 59AN XY: 74462
ClinVar
Submissions by phenotype
not provided Uncertain:1
The S106L variant of uncertain significance in the KCNE2 gene has been previously reported in one individualreferred for LQTS genetic testing, although no clinical information or segregation data was provided (Lieve et al.,2013). This variant has also been identified in other individuals referred for genetic testing at GeneDx; however, thusfar, segregation data is limited for these individuals due to the lack of clinical information provided and insufficientparticipation by informative family members. This variant is not observed at a significant frequency in largepopulation cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). In addition,S106L is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as theseresidues differ in polarity, charge, size and/or other properties. Nevertheless, S106L occurs at a position that is notconserved across species, and L106 is tolerated in at least two species. Furthermore, the majority of in silico toolspredicts this variant likely does not alter the protein structure/function. Therefore, based on the currently available information, it is unclear whether this variant is pathogenic or rare benign. -
Cardiovascular phenotype Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Long QT syndrome 6 Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at